biomarin pharmaceutical inc
(BM8:Frankfurt)

Executive Profile*

Background*

Mr. Jeffrey H. Cooper, Jeff, CPA, has been Chief Financial Officer of KaloBios Pharmaceuticals, Inc. since July 2012 and serves as Senior Vice President of finance and Principal Accounting Officer. Mr. Cooper served as an Advisor of BioMarin Pharmaceutical Inc. from July 1, 2012 to December 31, 2012. He served as the Chief Financial Officer and Senior Vice President of BioMarin Pharmaceutical Inc. from August 2005 and to June 2012. Mr. Cooper served as a Principal Accounting ... Officer of BioMarin Pharmaceutical Inc. until March 2, 2011. He served as a Vice President and Controller of BioMarin Pharmaceutical Inc. since October 2003 and as its Acting Chief Financial Officer since August 2004. Prior to BioMarin Pharmaceutical Inc., he served as the Vice President of Finance at Matrix Pharmaceutical, since November 2000 and served as its Finance Director, from February 1995 to September 1997 and its Senior Director of Finance, from August 1998 to October 2000. Earlier in his career, Mr. Cooper served in numerous finance-related roles within the health care and pharmaceutical industries, including Corporate Controller at Foundation Health Systems Inc., from September 1997 to July 1998. He served as Senior Accounting Manager and Director of Business Analysis at Syntex Corporation, a company he served for from 1983 to 1995. From 1980 to 1982, he worked in public accounting at Deloitte & Touche LLP. Mr. Cooper is a California Certified Public Accountant and earned an M.B.A. from Santa Clara University and a B.A. in Economics from the University of California, Los Angeles.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
BM8:GR	€50.93 EUR	+1.13

COMPETITOR COMPENSATION